RCRebecca L. Cunningham

Rebecca L. Cunningham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rebecca L. Cunningham has a total of 157 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Twenty years of sex and gender science in health research: a policy statement from the Organization for the Study of Sex Differences

    by Sofia B. Ahmed, Jill B. Becker, Katelyn A. Bruno, Sandra M. Dumanski, Liisa A. M. Galea, Marija Kundakovic, Armin Raznahan, Natalie C. Tronson, Rebecca L. Cunningham

    Sex and gender are fundamental determinants of health, disease risk, and treatment responses, yet they remain inconsistently and inadequately integrated into biomedical research. Despite major funding and regulatory policies over the past two decades, sex and gender continue to be treated primarily as descriptive variables rather than drivers of discovery. As the Organization for the Study of Sex Differences (OSSD) marks twenty years of leadership in this field, this policy statement articulates OSSD’s position on best practices for the integration of sex and gender in health research. Drawing on empirical evidence, landmark policies, and persistent gaps in implementation, this statement provides clear guidance for researchers, funders, and journals. OSSD explicitly recommends prespecified sex- and gender-responsive questions, appropriate study design and statistical power, transparent analysis and reporting, and accountability mechanisms to translate into practice. Adoption of these standards is essential to improving scientific rigor, reproducibility, and clinical relevance.


  • Open Access

    Advancing evidence-based regulation: Organization for the Study of Sex Differences and Society for Women’s Health Research support FDA action on menopausal hormone therapy and encourage broader sex-informed drug label updates

    by Rebecca L. Cunningham, Liisa A.M. Galea, Syreen Goulmamine, Georgios Kararigas, Kathryn G. Schubert, Kristen L. Zuloaga, Sofia B. Ahmed

    Menopause is an important life-stage transition with substantial implications for health and quality of life. Menopausal hormone therapy (HT) remains among the most effective treatments for menopausal symptoms, yet clinical uptake has varied markedly over time as evidence regarding benefits and risks has evolved. The Organization for the Study of Sex Differences and the Society for Women’s Health Research outline our support for the US Food and Drug Administration’s (FDA) removal of the “black box” warning on menopausal HT labels. This important shift in federal policy supports evidence-based menopause care and reflects an evolving, evidence-responsive regulatory practice. We further call for consistent, evidence-based FDA review of whether approved product labeling adequately incorporates sex-related differences in pharmacokinetics, pharmacodynamics, and adverse event profiles, with updates to indications, dosing, and warnings where supported by robust data.


  • Open Access

    Tiered Training and Licensure for the Future of the Pharmacy Profession: Panacea or Pandora's Box?

    by Katelyn M. Alexander, Julie B. Cooper, Jessica H. Hinson, Scott T. Benken, Sherrill Brown, Diane Calinski, Rebecca L. Cunningham, Julie A. Murphy, John M. Allen, Catherine Cone, et al.

  • Gestational chronic intermittent hypoxia triggers maternal inflammation and disrupts placental stress responses

    by Jennifer J. Gardner, Reneé de Nazaré Oliveira da Silva, Jessica L. Bradshaw, Steve Mabry, E. Nicole Wilson, Nataliia Hula, Selina M. Tucker, Isabelle K. Gorham, Desirae Escalera, Leslie Lopez, et al.

    Late-gestation exposure to even mild, short-term, chronic intermittent hypoxia (CIH) is sufficient to initiate maternal inflammation and disrupt key placental stress response mechanisms, despite occurring after placental development is largely complete. These findings highlight a novel temporal maternal and placental vulnerability in late pregnancy and identify novel targets for understanding the pathophysiology of hypoxia-related pregnancy complications.


  • Chronic intermittent hypoxia and ovariectomy exert independent and region-specific effects on ΔFosB expression and increase blood pressure in female rats

    by Cephas B. Appiah, Joel T. Little, George E. Farmer, Rebecca L. Cunningham, J. Thomas Cunningham

    We investigated the effects of ovarian hormone depletion and chronic intermittent hypoxia (CIH) on blood pressure and ΔFosB staining in central autonomic regions. Our findings indicate that ovariectomy (OVX) and CIH have independent effects on blood pressure and produce region-specific changes in ΔFosB staining in the central autonomic regions associated with hypertension. This suggests that the effects of CIH and OVX on ΔFosB staining and hypertension are not additive.


  • Open Access

    Gestational Chronic Intermittent Hypoxia Triggers Maternal Inflammation and Disrupts Placental Stress Responses

    by Jennifer Jordan Gardner, Reneé de Nazaré Oliveira da Silva, Jessica L. Bradshaw, Steve Mabry, Elizabeth Nicole Wilson, Nataliia Hula, Selina M. Tucker, Isabelle K. Gorham, Desirae Escalera, Leslie Lopez, et al.

    Gestational hypoxia is associated with placental cellular responses, including oxidative stress and inflammation. Circulating cell-free mitochondrial DNA (ccf-mtDNA) is a marker of cell stress, that can be transported within extracellular vehicles (EVs), eliciting proinflammatory responses. We hypothesized that systemic exposure to chronic intermittent hypoxia (CIH) during late pregnancy would increase maternal inflammation, alter circulating EV characteristics, and disrupt placental stress responses. Pregnant rats were exposed to CIH (n=8) or normoxia (n=9) during gestational days 15-20 (term 22-23 days). On GD20, ccf-mtDNA and EV-associated mtDNA (EV-mtDNA) were quantified with qRT-qPCR, while maternal circulating cytokines were quantified using a MILLIPLEX® cytokine array. Systemic oxidative stress was measured by plasma advanced oxidation protein products (AOPP). Placental stress responses were evaluated by examining the balance between proinflammatory and antioxidant gene expression and the activation of proteins involved in apoptotic and autophagic processes. CIH exposure increased placental weights (p=0.015) and reduced placental efficiency (p=0.0006) without affecting fetal biometrics (p>0.05). Absolute ccf-mtDNA and EV-mtDNA content were unchanged (p>0.05), but EV concentrations were reduced (p=0.011) in response to CIH, suggesting an increase in EV-mtDNA per EV. Maternal interleukin-18 (IL-18) concentrations increased in the CIH group (p=0.047). Placental mRNA expression of catalase (p=0.048) and sod2 (p=0.038) were upregulated, while autophagy-related proteins Beclin-1 (p=0.006) and p62 (p=0.023) were also increased in response to CIH, with no changes in LC3A/B expression (p>0.05). Gestational CIH disrupts maternal EV and inflammatory profiles, reduces placental efficiency, and modulates placental antioxidant and autophagic mechanisms, without impairing fetal growth in rats.


  • Chronic intermittent hypoxia modulates corneal fibrotic markers and inflammatory cytokine expression in a sex-dependent manner

    by Jessica L. Bradshaw, Brenda Vasini, Steve Mabry, Brenna S. Hefley, E. Nicole Wilson, Jennifer J. Gardner, Rebecca L. Cunningham, Dimitrios Karamichos


  • Open Access

    The impact of chronic intermittent hypoxia on enzymatic activity in memory-associated brain regions of male and female rats

    by Steve Mabry, Jessica L. Bradshaw, Jennifer J. Gardner, E. Nicole Wilson, Janak Sunuwar, Hannah Yeung, Sharad Shrestha, J. Thomas Cunningham, Rebecca L. Cunningham

    Background: Obstructive sleep apnea (OSA) is an intermittent hypoxia disorder associated with cognitive dysfunction, including learning and memory impairments. There is evidence that alterations in protease activity and neuronal activation are associated with cognitive dysfunction, are dependent on sex, and may be brain region-specific. However, the mechanisms mediating OSA-induced cognitive impairments are unclear. Therefore, we used a rat model of OSA, chronic intermittent hypoxia (CIH) to investigate protease activity (e.g., calpain and caspase-3) on spectrin, a cytoskeletal protein associated with neurotransmitter release, and neuronal activation (early growth response protein 1, EGR-1) in brain regions associated with learning and memory. Methods: Male and female Sprague Dawley rats were exposed to CIH or room air (normoxic) for 14 days. We quantified protease activity and cleaved spectrin products, along with EGR-1 protein expression in hippocampal subregions (CA1, CA3), cortical regions [entorhinal cortex (ETC), retrosplenial cortex (RSC), cerebellar cortex (CC)], and subcortical regions [raphe nucleus (RN), locus coeruleus (LC)] associated with learning and memory. Within each group, Pearson correlations of calpain activity, caspase-3 activity, and EGR-1 expression were performed between brain regions. Sex differences within normoxic and CIH correlations were examined. Results: CIH dysregulated calpain activity in male ETC, and female CA1 and RSC. CIH dysregulated caspase-3 activity in male RN, and female CA1 and RSC. CIH decreased calpain and caspase-3 cleavage products in male ETC. CIH decreased calpain-cleaved spectrin in male RSC but increased these products in female RSC. EGR-1 expression was decreased in male and female RN. Correlational analysis revealed CIH increased excitatory connections in males and increased inhibitory connections in females. EGR-1 expression in males shifted from negative to positive correlations. Conclusions: Overall, these data indicate CIH dysregulates protease activity and impairs neuronal function in a brain region- and sex-dependent manner. This indicates that males and females exhibit sex-specific vulnerabilities to mild OSA. These findings concur with our previous behavioral studies that demonstrated memory impairment in CIH-exposed rats.


  • Open Access

    Decreased Circulating Gonadotropin-Releasing Hormone Associated with Keratoconus

    by Paulina Escandon, Alexander J. Choi, Steve Mabry, Sarah E. Nicholas, Rebecca L. Cunningham, Liam Redden, David A. Murphy, Kamran M. Riaz, Tina B. McKay, Dimitrios Karamichos

    Keratoconus (KC) is a corneal thinning dystrophy that leads to visual impairment. While the cause of KC remains poorly understood, changes in sex hormone levels have been correlated with KC development. This study investigated circulating gonadotropin-releasing hormone (GnRH) in control and KC subjects to determine if this master hormone regulator is linked to the KC pathology. Plasma and saliva were collected from KC subjects (n = 227 and n = 274, respectively) and non-KC controls (n = 58 and n = 101, respectively), in concert with patient demographics and clinical features. GnRH levels in both plasma and saliva were significantly lower in KC subjects compared to controls. This finding was retained in plasma when subjects were stratified based on age, sex, and KC severity. Control and KC corneal fibroblasts (HKCs) stimulated with recombinant GnRH protein in vitro revealed significantly increased luteinizing hormone receptor by HKCs and reduced expression of α-smooth muscle actin with treatment suggesting that GnRH may modulate hormonal and fibrotic responses in the KC corneal stroma. Further studies are needed to reveal the role of the hypothalamic–pituitary–gonadal axis in the onset and progression of KC and to explore this pathway as a novel therapeutic target.


  • Open Access

    Ocular Inflammation and Oxidative Stress as a Result of Chronic Intermittent Hypoxia: A Rat Model of Sleep Apnea

    by Nina Donkor, Jennifer J. Gardner, Jessica L. Bradshaw, Rebecca L. Cunningham, Denise M. Inman

    Obstructive sleep apnea (OSA) is a sleep disorder characterized by intermittent complete or partial occlusion of the airway. Despite a recognized association between OSA and glaucoma, the nature of the underlying link remains unclear. In this study, we investigated whether mild OSA induces morphological, inflammatory, and metabolic changes in the retina resembling those seen in glaucoma using a rat model of OSA known as chronic intermittent hypoxia (CIH). Rats were randomly assigned to either normoxic or CIH groups. The CIH group was exposed to periodic hypoxia during its sleep phase with oxygen reduction from 21% to 10% and reoxygenation in 6 min cycles over 8 h/day. The eyes were subsequently enucleated, and then the retinas were evaluated for retinal ganglion cell number, oxidative stress, inflammatory markers, metabolic changes, and hypoxic response modulation using immunohistochemistry, multiplex assays, and capillary electrophoresis. Statistically significant differences were observed between normoxic and CIH groups for oxidative stress and inflammation, with CIH resulting in increased HIF-1α protein levels, higher oxidative stress marker 8-OHdG, and increased TNF-α. Pyruvate dehydrogenase kinase-1 protein was significantly reduced with CIH. No significant differences were found in retinal ganglion cell number. Our findings suggest that CIH induces oxidative stress, inflammation, and upregulation of HIF-1α in the retina, akin to early-stage glaucoma.